BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arabpour E, Khoshdel S, Tabatabaie N, Akhgarzad A, Zangiabadian M, Nasiri MJ. Stem Cells Therapy for COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:737590. [PMID: 34912818 DOI: 10.3389/fmed.2021.737590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Malueka RG, Nurudhin A, Purwoko P, Sumardi S, Wisaksana R, Adhiputri A, Sudadi S, Soeroto AY, Sidharta BRA, Thobari JA, Murni TW, Soewondo W, Herningtyas EH, Sudjud RW, Trisnawati I, Ananda NR, Faried A, Soetjahjo B. Effectiveness and Safety of Normoxic Allogenic Umbilical Cord Mesenchymal Stem Cells Administered as Adjunctive Treatment in Patients with Severe COVID-19.. [DOI: 10.21203/rs.3.rs-2280239/v1] [Reference Citation Analysis]
2 Yao W, Dong H, Qi J, Zhang Y, Shi L. Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2022;51:101545. [PMID: 35844767 DOI: 10.1016/j.eclinm.2022.101545] [Reference Citation Analysis]
3 Charitos IA, Ballini A, Lovero R, Castellaneta F, Colella M, Scacco S, Cantore S, Arrigoni R, Mastrangelo F, Dioguardi M. Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context. Int J Environ Res Public Health 2022;19. [PMID: 36078427 DOI: 10.3390/ijerph191710712] [Reference Citation Analysis]
4 Chen M, Lai KS, Chien K, Teng ST, Lin Y, Chao W, Lee M, Wei P, Huang Y, Kuo H, Weng C, Chou C. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury. Front Immunol 2022;13:871828. [DOI: 10.3389/fimmu.2022.871828] [Reference Citation Analysis]